Exane Derivatives’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $623 | Hold |
43
| – | – | ﹤0.01% | 550 |
|
|
2022
Q1 | $1.12K | Hold |
43
| – | – | ﹤0.01% | 794 |
|
|
2021
Q4 | $1.7K | Sell |
43
-2
| -4% | -$79 | ﹤0.01% | 660 |
|
|
2021
Q3 | $2.25K | Hold |
45
| – | – | ﹤0.01% | 776 |
|
|
2021
Q2 | $2.51K | Sell |
45
-43
| -49% | -$2.4K | ﹤0.01% | 788 |
|
|
2021
Q1 | $4.12K | Buy |
88
+13
| +17% | +$608 | ﹤0.01% | 612 |
|
|
2020
Q4 | $3.27K | Buy |
+75
| New | +$3.27K | ﹤0.01% | 571 |
|